Fig. 2
Kaplan Meier survival analysis of patients with an serum AFP above or below 200 ng/ml following initial TACE (AFP1)
Fig. 2 | BMC Cancer
Kaplan Meier survival analysis of patients with an serum AFP above or below 200 ng/ml following initial TACE (AFP1)